Roy Doumani
Executive Director

Roy is the Executive Director of the Business of Science Center and a professor at the David Geffen School of Medicine at UCLA teaching “The Business of Science”, “MedTech Innovations”, and “Healthcare Technology” to graduate students. He currently serves as Co-Chairman of the Zhejiang California NanoSystems Institute in China.

With a background in international finance, banking, and real estate, Roy holds an equity position in and served as Director of the first joint venture bank in the PRC, Xiamen International Bank and has been involved with numerous financial institutions: Founder and Director of First Los Angeles Bank; Chairman of First Interstate Bank of Hawaii; Director of HonFed Bank; Chairman of World Trade Bank in Los Angeles. Roy has served as a board member and advisor to companies in the United States, Asia, Europe and the Middle East. Roy was also involved in many startups included Agensys and Kite Pharma. Roy was a founder, investor, and director at Agensys, which sold for approximately $650 million. Currently Roy is a founder, investor, and director at Kite Pharma, which is being acquired by Gilead Sciences for approximately $12 billion and is currently Chairman of Neural Analytics.

Roy is a member of the Pacific Pension Institute’s advisory board. He has established endowed chairs at UCLA, in the Departments of Medical and Molecular Pharmacology and Urological Oncology.

Roy graduated from the University of California at Los Angeles (UCLA) with a degree in Business and Finance and received a law degree from the University of Southern California.